Generic Name and Formulations:
Metronidazole 0.75%; vaginal gel; contains parabens.
Medicis Pharmaceuticals Corp
Indications for METROGEL-VAGINAL:
One applicatorful once daily at bedtime, or twice daily, for 5 days.
Discontinue if abnormal neurological signs develop. CNS or hepatic disease. Abstain from vaginal intercourse during therapy. Pregnancy (Cat.B). Nursing mothers: not recommended.
Avoid concomitant alcohol. May potentiate oral anticoagulants, lithium. May be potentiated by cimetidine.
Superinfection, local irritation, GI discomfort/upset, headache, abnormal taste, dizziness, decreased appetite, change in WBC counts.
Gel—70g (w. applicators)
Neurology Advisor Articles
- Gender and Multiple Sclerosis: How It Influences Prognosis and Future Treatment
- Natalizumab Improves Cognitive Function in Multiple Sclerosis
- Significant Variations in Epilepsy Surgical Strategy, Deficit Reporting Exist
- Thrombolysis With Tenecteplase Is as Safe as Alteplase in Stroke Mimics
- Smoking Promotes Disease Progression in Multiple Sclerosis
- 5 Key Findings Presented at 2018 Parkinson Disease Conference
- Parkinson Disease and the Gut: Treatment Potential Abounds
- Managing Comorbid Migraine and Mood Disorders: A Synergistic Approach
- Stroke-Code Patients With Low NIHSS Score, No Acute Imaging Findings Often Misdiagnosed
- Ethical Challenges of Nusinersen: Considerations When Counseling on Treatment
- Deep Brain Stimulation Reduces Tremor Symptoms in Parkinson Disease
- FDA Issues Statement Addressing Safety Concerns Associated With Nuplazid
- Prevalence of Autoimmune Encephalitis in Herpes Simplex Encephalitis Explored
- Chronic Cluster Headaches Improve With High-Volume Suboccipital Nerve Blocks
- Multiple Sclerosis Increases Risk for Infection During Pregnancy